PHI with Malignant pleural mesothelioma
How does this condition affect your private health insurance?
Malignant Pleural Mesothelioma (Rippenfell Ca) is an aggressive, rare cancer originating in the pleura, the lining of the lungs and chest cavity. Primarily caused by asbestos exposure, symptoms like shortness of breath, chest pain, and weight loss often appear decades after exposure. Diagnosis involves imaging, biopsy, and pathological examination. Due to late presentation and aggressive nature, prognosis is generally poor. Treatment combines surgery, chemotherapy, and radiation, often aimed at disease control and symptom management rather than cure. Immunotherapy and targeted therapies offer emerging hope, but complete recovery remains exceedingly challenging for most patients.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically several weeks of noticeable symptoms before diagnosis, followed by a progressive course often lasting months to a few years post-diagnosis.
Duration of Illness (Lifetime)
A chronic, progressive disease from diagnosis until death, usually spanning months to a few years.
Cost of Treatment (Initial)
Tens of thousands to hundreds of thousands of dollars for initial diagnostic procedures, staging, and the first rounds of chemotherapy, radiation, or surgery.
Cost of Treatment (Lifetime)
Hundreds of thousands to well over a million dollars, encompassing surgery, chemotherapy, radiation, targeted therapies, immunotherapy, palliative care, and supportive measures.
Mortality Rate
Very high; prognosis is generally poor, with a median survival often less than two years and 5-year survival rates typically below 10%.
Risk of Secondary Damages
High, including respiratory failure, pain, fluid accumulation (effusions), cachexia, and potential spread to other organs. Treatment side effects (e.g., neuropathy, fatigue, nausea) also cause significant damage.
Probability of Full Recovery
Very low, close to 0-5%. Complete eradication of the disease is extremely challenging, and recurrence is common.
Underlying Disease Risk
While not typically caused by other 'underlying diseases,' a history of asbestos exposure is the primary risk factor. Co-occurrence with other asbestos-related conditions like asbestosis or asbestos-related lung cancer is possible but less common than mesothelioma as a standalone primary diagnosis.